Science | Gemo

2019

Intracardiac cement embolism during percutaneous vertebroplasty: incidence, risk factors and clinical management

Fadili Hassani S, Cormier E, Shotar E, Drir M, Spano JP, Morardet L, Collet JP, Chiras J, Clarençon F.

Journal: European Radiology
Volume: 29, Issue 2
Année: Février 2019
Pages: 663-673

https://doi.org/10.1007/s00330-018-5647-0

A real-world study assessing the use of bone-targeted agents and their impact on bone metastases in patients with prostate cancer treated in clinical practice in Europe

Body JJ, von Moos R, Rider A, Hallworth P, Bhowmik D, Gatta F, Hechmati G, Qian Y

Journal: Journal of Bone Oncology
Volume: 14
Année: Février 2019
Pages:100212

https://doi.org/10.1016/j.jbo.2018.100212

French recommendations for osteoporosis prevention and treatment in patients with prostate cancer treated by androgen deprivation

Briot K, Paccou J, Beuzeboc P, Bonneterre J, Bouvard B, Confavreux CB, Cormier C, Cortet B, Hannoun-Lévi JM, Hennequin C, Javier RM, Lespessailles E, Mayeur D, Mongiat Artus P, Vieillard MH, Debiais F

Journal: Joint Bone Spine
Volume: 86, Issue 1
Année: Janvier 2019
Pages: 21-28

https://doi.org/10.1016/j.jbspin.2018.09.017

2018

TMPRSS2:ERG gene fusion expression regulates bone markers and enhances the osteoblastic phenotype of prostate cancer bone metastases

Delliaux C, Tian TV, Bouchet M, Fradet A, Vanpouille N, Florens A, Deplus R, Villers A, Leroy X, Clézardin P, De Launoit Y, Bonnelye E, Duterque-Coquillaud M

Journal: Cancer Letters
Volume: 438
Année: Décembre 2018
Pages: 32-43

https://doi.org/10.1016/j.canlet.2018.08.027